Sequential Cleavage and Excision of a Segment of the Thyrotropin Receptor Ectodomain*

Abstract

The thyrotropin (TSH) receptor belongs to a subfamily of G protein-coupled receptors, which also includes luteinizing hormone and follicle-stimulating hormone receptors. The TSH receptor (TSHR) differs from the latter by the presence of an additional specific segment in the C-terminal part of its ectodomain. We show here that this insertion is excised in the majority of receptor molecules. Preparation of specific monoclonal antibodies to this region, microsequencing, enzyme-linked immunosorbent assay, and immunoblot studies have provided insight into the mechanisms of this excision. In the human thyroid gland, N termini of the transmembrane receptor β subunit were found to be phenylalanine 366 and leucines 370 and 378. In transfected L cells a variety of other more proximal N termini were found, probably corresponding to incomplete excisions. The most extreme N terminus was observed to lie at Ser-314. These observations suggest that after initial cleavage at Ser-314 the inserted fragment of TSHR is progressively clipped out by a series of cleavage reactions progressing up to amino acids 366–378. The impossibility of recovering the excised fragment from purified receptor, cell membranes, or culture medium supports this interpretation. The cleavage enzyme has previously been shown to be inhibited by BB-2116, an inhibitor of matrix metalloproteases. However, we show here that it is unaffected by tissue inhibitors of metalloproteases. The cleavage enzyme is very similar to TACE (tumor necrosis factor α-converting enzyme) in both these characteristics. However, incubation of the TSH receptor with the purified recombinant catalytic domain of TACE, co-transfection of cells with TACE and TSHR expression vectors, and the use of mutated Chinese hamster ovary cells in which TACE is inactive suggested that the TSHR cleavage enzyme is different from TACE. TACE and TSHR cleavage enzyme may thus possibly be related but different members of the adamalysin family of metzincin metalloproteases.

Footnotes

  • * This work was supported by the Institut National de la Santé et de la Recherche Médicale, the Institut de Formation Supérieure Biomédicale, the Faculté de Médecine Paris Sud, the Association pour la Recherche sur le Cancer and the Délégation à la Recherche Clinique, Assistance Publique Hôpitaux de Paris Grant CRC 94199.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • To whom correspondence should be addressed: INSERM U. 135, Hôpital de Bicêtre, 3ème niveau, 94275 Le Kremlin Bicêtre, France. Tel.: 33-1-45-21-33-29; Fax: 33-1-45-21-27-51; E-mail: milgrom{at}infobiogen.fr.

  • Abbreviations:
    TSH

    thyrotropin

    TSHR

    TSH receptor

    Ecto-Ab

    Endo-Ab, and Del-Ab, antibodies recognizing, respectively, receptor ectodomain, endodomain, and the putative deleted fragment

    MMP

    matrix metalloprotease

    TIMP

    tissue inhibitor of metalloproteases

    TNF

    tumor necrosis factor

    TACE

    TNFα converting enzyme

    TGF

    transforming growth factor

    BSA

    bovine serum albumin

    ELISA

    enzyme-linked immunosorbent assay

    CHO

    Chinese hamster ovary

    HA

    hemagglutinin.

    • Received July 29, 1998.
    • Revision received October 5, 1998.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement